Outcomes of transfemoral transcatheter aortic valve implantation (TAVI) and predictors of thirty-day major adverse cardiovascular events (MACE) and one-year mortality.

CONCLUSION: We have shown excellent 30-day results with low incidence of adverse events with both the balloon expandable and self-expandable valves. Mainly clinical factors are predictors of both 30-day MACE and one-year mortality; major VC is a strong predictor of one-year mortality. PMID: 33007466 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Cardiology - Category: Cardiology Tags: Hellenic J Cardiol Source Type: research